ELM Elementis plc
Elementis plc operates as a specialty chemical company in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Coatings and Personal Care. The Coatings segment offers production of rheological modifiers and additives for decorative and industrial coatings; and performance chemicals for the energy sector. This segment provides products for applications in architectural and industrial coatings, adhesives, and sealants and construction additives. The Personal Care segment offers rheological modifiers and compounded products, including active ingredients for antiperspirants (AP) deodorants for personal care manufacturers. This segment offers products for applications in antiperspirants, skin care, and color cosmetics. Elementis plc was founded in 1884 and is headquartered in London, the United Kingdom.…
Industry Peers
Specialty ChemicalsKey Statistics
About Elementis (LON: ELM)
›
Elementis (LON: ELM) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 989 employees.
The shares were at 189.00 GBp on 19 November 2026, up 16.5% over 52 weeks.
At a market capitalisation of 1.06B GBP, it trades at 21.0 times trailing earnings and 15.2 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, a discount of 38% for ELM. It pays a dividend yielding 1.75% (it pays out 35% of its earnings), against a median of 1.76% among the dividend payers in that peer group.
Elementis reports return on equity of -7.1%, an operating margin of 22.1% and revenue up 9.4% year over year.
Its debt exceeds its cash by 178.30M USD, a debt-to-equity ratio of 0.40. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 8 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 217.62 GBp is 15.1% above the current price. The next earnings report is expected on 2 March 2027.